Compound niclosamide chewing tablet used for dogs and cats
A technology of compound niclosamide and niclosamide, applied in the field of compound niclosamide chewable tablets and its preparation, to achieve good taste, improve oral bioavailability, and increase compliance
Inactive Publication Date: 2014-06-25
QINGDAO VLAND BIOTECH INC
View PDF0 Cites 1 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Changshanone is a new broad-spectrum anticoccidial drug, no adverse reactions have been found so far, and there is no cross-resistance with other anticoccidial drugs
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreExamples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0017] Prescription composition:
[0018] Niclosamide 10mg
[0019] Praziquantel 5mg
[0020] Pyrantel 15mg
[0021] Hemosanone 5mg
[0022] Microcrystalline Cellulose 23mg
[0023] Starch 30mg
[0025] Beef Flavor 10mg
[0026] Total 100mg per tablet
[0027] Preparation method: Pass praziquantel, pyrantel, niclosamide, fushenone, microcrystalline cellulose, and starch through a 100-mesh sieve and mix evenly, use an appropriate amount of alcohol to make a soft material, granulate with a 20-mesh sieve, dry, and use a 20-mesh sieve Sieve whole grains, add beef essence and magnesium stearate, mix well, and press into tablets to obtain.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention discloses a compound niclosamide chewing tablet used for dogs and cats. The active components of the chewing tablet comprise praziquantel, pyrantel, niclosamide and halofuginone. The chewing tablet overcomes a disadvantage of poor palatability of traditional tablets, allows the dogs and the cats to fully chew the medicine, and guarantees full adsorption of the medicine and exertion of good medicine effects. The tablet provided by the invention comprises following components by weight: 10-20% of the niclosamide, 5-10% of the praziquantel, 15-25% of the pyrantel, 5-10% of the halofuginone, 30-50% of a filling agent, 0.5-3% of an adhesive and 5-15% of a corrigent. The chewing tablet is simple in preparation process, good in product taste, stable in product quality, and suitable for industrial production.
Description
technical field [0001] The invention relates to a compound niclosamide chewable tablet for expelling nematodes, tapeworms and protozoa in dogs and cats and a preparation method thereof. Background technique [0002] At present, there are many medicines for treating nematodes and tapeworms in dogs and cats in the pet market, but due to the serious mixed feeling of parasites in pets, there is currently a lack of antiparasitic medicines on the market that can treat nematodes, tapeworms and protozoa at the same time. Therefore, we have developed a highly efficient, comprehensive and safe antiparasitic drug. Its main ingredients include praziquantel (Praziquantel), pyrantel (Pyrantel), niclosamide (Febental) and halofuginone (Halofuginone). Praziquantel is clinically effective against Schistosomiasis japonicum, Taeniasis, Clonorchiasis, and Paragonimiasis. Pyrantel is mainly used clinically to drive away roundworms, hookworms, and pinworms. Niclosamide is a benzimidazole precu...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): A61K31/517A61K31/506A61K31/4985A61K31/167A61K9/20A61P33/10A61P33/02A61P33/00
Inventor 张瑞丽邱梅
Owner QINGDAO VLAND BIOTECH INC